Bioavailability of a pediatric amlodipine suspension

Pediatric Nephrology

Volumn 18, Issue 7, 2003, Pages 675-678

  Lyszkiewicz, Dorothy A ^a   Levichek, Zina ^a   Kozer, Eran ^a   Yagev, Yaron ^a   Moretti, Myla ^a   Hard, Marjie ^a   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Amlodipine; Bioavailability; Bioequivalence; Pediatric formulation; Stability; Suspension

Indexed keywords

AMLODIPINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BIOAVAILABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NORMAL HUMAN; PEDIATRICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSPENSION; TABLET FORMULATION; VOLUNTEER;

EID: 0038353780     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1088-2     Document Type: Article

References (14)

1. Pfammatter JP, Clericetti-Affolter C, Truttmann AC, Busch K, Laux-End R, Bianchetti MG (1998) Amlodipine once daily in systemic hypertension. Eur J Pediatr 157:618-621
2. Khattak S, Rogan JW, Saunders EF, Theis JG, Arbus GS, Koren G (1998) Efficacy of amlodipine in pediatric bone marrow transplant patients. Clin Pediatr (Phila) 37:31-35
3. Silverstein DM, Palmer J, Baluarte HJ, Brass C, Conley SB, Polinsky MS (1999) Use of calcium-channel blockers in pediatric renal transplant recipients. Pediatr Transplant 3:288-292
4. Tallian KB, Nahata MC, Turman MA, Mahan JD, Hayes JR, Menster MI (1999) Efficacy of amlodipine in pediatric patients with hypertension. Pediatr Nephrol 13:304-310
5. Flynn JT, Smoyer WE, Bunchman TE (2000) Treatment of hypertensive children with amlodipine. Am J Hypertens 13:1061-1066
6. Rogan JW, Lyszkiewicz DA, Blowey D, Khattak S, Arbus GS, Koren G (2000) A randomized prospective crossover trial of amlodipine in pediatric hypertension. Pediatr Nephrol 14: 1083-1087
7. von Vigier RO, Franscini LM, Bianda ND, Pfister R, Casaulta Aebischer C, Bianchetti MG (2001) Antihypertensive efficacy of amlodipine in children with chronic kidney diseases. J Hum Hypertens 15:387-391
8. Temple ME, Nahata MC (2000) Treatment of pediatric hypertension. Pharmacotherapy 20:140-150
9. Nahata MC, Morosco RS, Hipple TF (1999) Stability of amlodipine besylate in two liquid dosage forms. J Am Pharm Assoc 39:375-377
10. Meyer MC (2001) United States Food and Drug Administration requirements for approval of generic drug products. J Clin Psychiatry 62 [Suppl] 5:4-9
11. Drugs Directorate Guidelines (1992) Conduct and analysis of bioavailability and bioequivalence studies. A. Oral dosage formulations used for systemic effects. Therapeutic Products Directorate, Health Canada
12. Rippley RK, Conner J, Bradstreet TE, Hand E, Lo MW, Murphy MG (2000) Pharmacokinetic assessment of an oral enalapril suspension for use in children. Biopharm Drug Disops 21:339-344
13. Smith AL, Meeks CA, Koup JR, Opheim KE, Weber A, Vishwanathar CT (1990) Dicloxacillin absorption and elimination in children. Dev Pharmacol Ther 14:35-44
14. Faulkner JK, Hayden ML, Chasseaud LF, Taylor T (1989) Absorption of amlodipine unaffected by food. Solid dose equivalent to solution dose. Arzneimittelforschung 39:799-801